Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 18, 2014 08:00 ET | Source: Foamix, Ltd.

Foamix Pharmaceuticals to Present at the 2014 BIO International Convention on June 26th in San Diego

REHOVOT, Israel and BRIDGEWATER, N.J., June 18, 2014 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals (the "Company"), a clinical stage specialty pharmaceutical company focused on the development, patenting...
June 11, 2014 10:28 ET | Source: Foamix, Ltd.

Foamix Establishes U.S. Subsidiary and Strengthens Executive Management With Appointment of Senior U.S. Leadership Team

New Senior Managers and Advisors Were Previously at Warner-Chilcott Inc., Overseeing Revenue Growth from $117 Million in 2001 to More Than $2.7 Billion in 2011. Team Brings Expertise in...
June 03, 2014 08:00 ET | Source: Foamix, Ltd.

Foamix Announces Collaboration With National Institutes of Health

REHOVOT, Israel, June 3, 2014 (GLOBE NEWSWIRE) -- Foamix, a clinical-stage, specialty pharmaceutical company today announced a collaboration agreement with the National Eye Institute (NEI), one of the...
April 21, 2014 08:00 ET | Source: Foamix, Ltd.

Foamix Announces the Issuance of Five Additional US Patents

REHOVOT, Israel, April 21, 2014 (GLOBE NEWSWIRE) -- Foamix, a clinical-stage, specialty pharmaceutical company, focused on the development, patenting and commercialization of proprietary topical foams...
February 27, 2014 09:13 ET | Source: Foamix, Ltd.

Foamix, Ltd., to Present at the 34th Annual Cowen & Company Health Care Conference -- Successful Phase 2 for First Ever Topical Minocycline for Acne and Impetigo

REHOVOT, Israel, Feb. 27, 2014 (GLOBE NEWSWIRE) -- Foamix, a clinical-stage, privately held specialty pharmaceutical company, focused on the development of proprietary topical foams for dermatology...